AVNS (Avanos Medical) Cyclically Adjusted Revenue per Share: $16.09 (As of Mar. 2026)


AVNS Avanos Medical Inc AVNS
62 GF Score
Price $24.93
GF Value $19.39
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Avanos Medical Cyclically Adjusted Revenue per Share?

Avanos Medical AVNS -0.04% 62 Cyclically Adjusted Revenue per Share is $16.09 as of Mar. 2026. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.39 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Avanos Medical's adjusted revenue per share for the three months ended in Mar. 2026 was $3.836. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $16.09 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Avanos Medical's average Cyclically Adjusted Revenue Growth Rate was 3.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Avanos Medical was -8.20% per year. The lowest was -8.20% per year. And the median was -8.20% per year.

As of today (2026-07-11), Avanos Medical's current stock price is $24.93. Avanos Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $16.09. Avanos Medical's Cyclically Adjusted PS Ratio of today is 1.55.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Avanos Medical was 1.56. The lowest was 0.68. And the median was 1.06.


Avanos Medical  (NYSE:AVNS) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Avanos Medical's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=24.93/16.09
=1.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Avanos Medical was 1.56. The lowest was 0.68. And the median was 1.06.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Avanos Medical Cyclically Adjusted Revenue per Share Related Terms


Avanos Medical Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Avanos Medical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avanos Medical Cyclically Adjusted Revenue per Share Chart

Avanos Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 21.40 18.82 16.06 16.54

Avanos Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.49 14.88 14.23 16.54 16.09

AVNS vs LMRI, AORT, IRMD: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Avanos Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avanos Medical Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Avanos Medical's Cyclically Adjusted PS Ratio falls into.


AVNS
62GF Score
Avanos Medical Inc AVNS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avanos Medical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Avanos Medical's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.836/330.2130*330.2130
=3.836

Current CPI (Mar. 2026) = 330.2130.

Avanos Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 8.529 241.018 11.685
201609 8.422 241.428 11.519
201612 -13.221 241.432 -18.083
201703 3.120 243.801 4.226
201706 3.193 244.955 4.304
201709 3.216 246.819 4.303
201712 3.531 246.524 4.730
201803 3.335 249.554 4.413
201806 3.338 251.989 4.374
201809 3.397 252.439 4.444
201812 3.577 251.233 4.701
201903 3.457 254.202 4.491
201906 3.618 256.143 4.664
201909 3.593 256.759 4.621
201912 3.987 256.974 5.123
202003 3.758 258.115 4.808
202006 3.425 257.797 4.387
202009 3.861 260.280 4.898
202012 3.870 260.474 4.906
202103 3.765 264.877 4.694
202106 3.835 271.696 4.661
202109 3.827 274.310 4.607
202112 0.715 278.802 0.847
202203 4.130 287.504 4.744
202206 3.590 296.311 4.001
202209 3.666 296.808 4.079
202212 3.889 296.797 4.327
202303 3.418 301.836 3.739
202306 3.620 305.109 3.918
202309 3.660 307.789 3.927
202312 3.743 306.746 4.029
202403 3.557 312.332 3.761
202406 3.708 314.175 3.897
202409 3.657 315.301 3.830
202412 3.904 315.605 4.085
202503 3.579 319.799 3.696
202506 3.780 322.561 3.870
202509 3.832 324.800 3.896
202512 3.907 324.054 3.981
202603 3.836 330.213 3.836

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $16.09 mean?
Avanos Medical (AVNS) has a Cyclically Adjusted Revenue per Share of $16.09 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Avanos Medical and its competitors.
Is Avanos Medical's Cyclically Adjusted Revenue per Share too high?
Avanos Medical's current Cyclically Adjusted Revenue per Share is $16.09. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's Cyclically Adjusted Revenue per Share compare to LMRI and AORT?
Avanos Medical's Cyclically Adjusted Revenue per Share of $16.09 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Avanos Medical and its competitors. Avanos Medical's current Cyclically Adjusted Revenue per Share is $16.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.39, compared to a current price of $24.93 — trading 28.6% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $16.09. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Avanos Medical (AVNS), the current Cyclically Adjusted Revenue per Share is $16.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Avanos Medical (AVNS) Overvalued in 2026?

Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued. The current stock price of $24.93 is trading 28.6% above its estimated GF Value™ of $19.39. GuruFocus considers Avanos Medical to be Modestly Overvalued.

Key valuation signals for AVNS:

  • Cyclically Adjusted Revenue per Share: $16.09
  • GF Value™: $19.39 vs. price of $24.93 (28.6% above fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Avanos Medical Business Description

Address 5405 Windward Parkway, Suite 100 South, Alpharetta, GA, USA, 30004
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score

Get the complete analysis for AVNS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.93
Price
$19.39
GF Value